Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SINOPEC CORP
00386
5
CNOOC
00883
| (Q6)Sep 30, 2025 | (FY)Mar 31, 2025 | (Q6)Sep 30, 2024 | (FY)Mar 31, 2024 | (Q6)Sep 30, 2023 | (FY)Mar 31, 2023 | (Q6)Sep 30, 2022 | (FY)Mar 31, 2022 | (Q6)Sep 30, 2021 | (FY)Mar 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash flow from operating activities | ||||||||||
| Earning before tax | ---- | 23.99%-16.04M | ---- | -118.02%-21.1M | ---- | -121.47%-9.68M | ---- | -35.83%45.07M | ---- | 162.55%70.24M |
| Profit adjustment | ||||||||||
| Interest (income) - adjustment | ---- | 53.56%-1.12M | ---- | 41.99%-2.4M | ---- | -9.82%-4.14M | ---- | -281.09%-3.77M | ---- | -62.66%-989K |
| Dividend (income)- adjustment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 0.00%-750K | ---- | 0.00%-750K |
| Attributable subsidiary (profit) loss | ---- | -81.12%88K | ---- | 417.78%466K | ---- | 129.61%90K | ---- | -400.99%-304K | ---- | -99.08%101K |
| Impairment and provisions: | ---- | -99.76%20K | ---- | 1,485.90%8.44M | ---- | -73.24%532K | ---- | --1.99M | ---- | ---- |
| -Impairmen of inventory (reversal) | ---- | ---- | ---- | --18K | ---- | ---- | ---- | --1.43M | ---- | ---- |
| -Impairment of trade receivables (reversal) | ---- | -99.76%20K | ---- | --8.42M | ---- | ---- | ---- | ---- | ---- | ---- |
| -Other impairments and provisions | ---- | ---- | ---- | ---- | ---- | -4.49%532K | ---- | --557K | ---- | ---- |
| Revaluation surplus: | ---- | -23.57%2.66M | ---- | 174.80%3.48M | ---- | -73.91%1.27M | ---- | 335.55%4.85M | ---- | 147.32%1.11M |
| -Fair value of investment properties (increase) | ---- | 350.00%2.34M | ---- | 140.00%520K | ---- | -285.71%-1.3M | ---- | -68.75%700K | ---- | 507.27%2.24M |
| -Other fair value changes | ---- | -89.22%319K | ---- | 15.32%2.96M | ---- | -38.20%2.57M | ---- | 468.74%4.15M | ---- | 37.58%-1.13M |
| Asset sale loss (gain): | ---- | -188.24%-245K | ---- | ---85K | ---- | ---- | ---- | -3,088.58%-7.59M | ---- | 1,370.00%254K |
| -Loss (gain) from sale of subsidiary company | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -1,686.73%-7.27M | ---- | ---407K |
| -Loss (gain) on sale of property, machinery and equipment | ---- | -11.76%-95K | ---- | ---85K | ---- | ---- | ---- | -148.26%-319K | ---- | 3,405.00%661K |
| -Loss (gain) from selling other assets | ---- | ---150K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization: | ---- | -5.45%347K | ---- | 9.23%367K | ---- | -83.28%336K | ---- | -92.69%2.01M | ---- | 0.75%27.5M |
| -Depreciation | ---- | -5.45%347K | ---- | 9.23%367K | ---- | -83.28%336K | ---- | -92.69%2.01M | ---- | 0.75%27.5M |
| Financial expense | ---- | -14.29%186K | ---- | -8.05%217K | ---- | -64.08%236K | ---- | -3.24%657K | ---- | -1.88%679K |
| Special items | ---- | -41.67%231K | ---- | --396K | ---- | ---- | ---- | ---- | ---- | ---- |
| Operating profit before the change of operating capital | ---- | -35.66%-13.86M | ---- | 10.00%-10.22M | ---- | -126.93%-11.36M | ---- | -57.04%42.17M | ---- | 215.05%98.15M |
| Change of operating capital | ||||||||||
| Inventory (increase) decrease | ---- | -328.17%-4.89M | ---- | -38,200.00%-1.14M | ---- | -99.97%3K | ---- | 18,133.33%8.66M | ---- | -100.61%-48K |
| Accounts receivable (increase)decrease | ---- | ---3.21M | ---- | ---- | ---- | -99.87%5K | ---- | 205.81%3.71M | ---- | ---3.51M |
| Accounts payable increase (decrease) | ---- | 777.66%8.01M | ---- | -625.15%-1.18M | ---- | 96.86%-163K | ---- | -222.66%-5.19M | ---- | 1,093.66%4.23M |
| prepayments (increase)decrease | ---- | 163.70%3.47M | ---- | -184.36%-5.45M | ---- | -62.98%6.46M | ---- | 1,185.26%17.44M | ---- | 524.06%1.36M |
| Special items for working capital changes | ---- | 63.91%-1.08M | ---- | ---3M | ---- | ---- | ---- | ---- | ---- | ---1.5M |
| Cash from business operations | ---- | 44.87%-11.57M | ---- | -315.41%-21M | ---- | -107.57%-5.05M | ---- | -32.32%66.78M | ---- | 158.12%98.68M |
| Other taxs | ---- | ---621K | ---622K | ---- | ---- | 94.48%-999K | 97.98%-333K | -35.05%-18.11M | -446.77%-16.49M | -49.29%-13.41M |
| Special items of business | -1,599.44%-12.24M | ---- | 81.45%-720K | ---- | 32.49%-3.88M | ---- | -107.20%-5.75M | ---- | 1,666.96%79.9M | ---- |
| Net cash from operations | -811.77%-12.24M | 41.91%-12.2M | 65.43%-1.34M | -246.85%-21M | 36.18%-3.88M | -112.44%-6.05M | -109.59%-6.08M | -42.91%48.68M | 4,108.16%63.42M | 191.53%85.27M |
| Cash flow from investment activities | ||||||||||
| Interest received - investment | -40.23%468K | -44.42%1.1M | -30.65%783K | -45.17%1.98M | -45.25%1.13M | 7.18%3.61M | 64.57%2.06M | 240.85%3.37M | 451.98%1.25M | 62.66%989K |
| Dividend received - investment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 0.00%750K | ---- | 0.00%750K |
| Decrease in deposits (increase) | -132.67%-10.92M | --0 | --33.42M | ---32.66M | ---- | ---- | ---- | ---- | ---- | ---- |
| Sale of fixed assets | ---- | 11.76%95K | ---- | --85K | --85K | ---- | ---- | --319K | ---- | ---- |
| Purchase of fixed assets | -12,480.00%-629K | 94.59%-4K | ---5K | 85.96%-74K | ---- | -1,021.28%-527K | ---- | ---47K | ---- | ---- |
| Purchase of intangible assets | ---- | ---780K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---11.66M |
| Sale of subsidiaries | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --407K |
| Acquisition of subsidiaries | ---- | ---- | ---- | -30.00%-195K | ---195K | ---150K | ---- | ---- | ---- | ---- |
| Recovery of cash from investments | -70.00%45K | -98.62%150K | -98.60%150K | 600.51%10.89M | 590.23%10.73M | -82.35%1.55M | --1.56M | --8.81M | ---- | ---- |
| Cash on investment | 78.16%-311K | -414.29%-2.92M | -315.16%-1.42M | 95.43%-567K | ---343K | 10.02%-12.4M | ---- | ---13.78M | ---- | ---- |
| Other items in the investment business | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --124K | ---- |
| Net cash from investment operations | -134.46%-11.34M | 88.54%-2.35M | 188.55%32.92M | -159.73%-20.54M | 215.43%11.41M | -1,261.27%-7.91M | 162.67%3.62M | 93.89%-581K | 117.19%1.38M | -4,497.10%-9.52M |
| Net cash before financing | -174.67%-23.58M | 64.97%-14.55M | 319.54%31.58M | -197.50%-41.54M | 405.23%7.53M | -129.03%-13.96M | -103.81%-2.47M | -36.51%48.1M | 2,926.34%64.79M | 160.84%75.75M |
| Cash flow from financing activities | ||||||||||
| New borrowing | --30M | -200.00%-9.8M | ---- | 8.89%9.8M | ---- | 45.16%9M | ---- | --6.2M | ---- | ---- |
| Refund | ---- | ---- | 27.78%-6.5M | 19.64%-9M | -80.00%-9M | -12.00%-11.2M | ---5M | ---10M | ---- | ---- |
| Issuing shares | ---- | 216.93%30.7M | ---- | --9.69M | ---- | ---- | ---- | ---- | ---- | ---- |
| Interest paid - financing | ---- | 15.45%-186K | ---- | 5.58%-220K | ---- | 64.54%-233K | ---- | 3.24%-657K | ---- | 1.88%-679K |
| Dividends paid - financing | ---- | -196.79%-16M | -196.79%-16M | 53.21%-5.39M | ---5.39M | 69.25%-11.52M | ---- | -187.37%-37.47M | ---27.7M | 27.73%-13.04M |
| Absorb investment income | ---- | --792K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
| Issuance expenses and redemption of securities expenses | ---- | 32.11%-258K | ---- | ---380K | ---- | ---- | ---- | ---- | ---- | ---- |
| Other items of the financing business | 87.02%-17K | ---- | -194.93%-131K | ---- | 187.90%138K | ---- | 53.55%-157K | ---- | 0.00%-338K | ---- |
| Net cash from financing operations | 232.50%29.98M | 16.83%5.26M | -58.77%-22.63M | 132.24%4.5M | -176.36%-14.25M | 66.72%-13.95M | 81.61%-5.16M | -201.90%-41.92M | -8,196.15%-28.04M | 30.74%-13.89M |
| Effect of rate | -76.88%120K | 98.93%-38K | 112.47%519K | 56.84%-3.57M | 68.29%-4.16M | -271.49%-8.27M | -738.95%-13.12M | -23.43%4.82M | 26.24%2.05M | 336.74%6.3M |
| Net Cash | -28.47%6.4M | 74.91%-9.29M | 233.10%8.95M | -32.69%-37.04M | 11.78%-6.73M | -552.20%-27.91M | -120.74%-7.62M | -90.02%6.17M | 1,938.44%36.75M | 588.00%61.87M |
| Begining period cash | -18.56%40.95M | -44.68%50.28M | -44.68%50.28M | -28.47%90.89M | -28.47%90.89M | 9.47%127.07M | 9.47%127.07M | 142.26%116.07M | 142.26%116.07M | 15.23%47.91M |
| Cash at the end | -20.55%47.47M | -18.56%40.95M | -25.31%59.75M | -44.68%50.28M | -24.76%80M | -28.47%90.89M | -31.35%106.32M | 9.47%127.07M | 201.66%154.88M | 142.26%116.07M |
| Cash balance analysis | ||||||||||
| Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion | -- | Unqualified Opinion |
| Auditor | -- | Zhongzheng Tianheng Certified Public Accountants Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. | -- | National Health Accounting Firm Co., Ltd. |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.